FDA Inspection 1054286 — UC Reproductive Medicine at Kettering
The FDA completed an inspection of UC Reproductive Medicine at Kettering on May 16, 2018 in Kettering, OH. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 16, 2018
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Kettering, OH (United States)